It is a complex chronic disease treated with various methods; common anti-obesity drugs include orlistat, which inhibits pancreatic lipase to reduce fat absorption, and sibutramine, which suppresses appetite and increases energy expenditure [12,13]. Here, PNLIP is linked to obesity disorder.